FDA Officials OK New Generic Valsartan – APhA submits compounding comments to FDA.

16321_pharmacyboard_standard_080416Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

FDA Officials OK New Generic Valsartan – APhA submits compounding comments to FDA. – (866) 348-2889.

Officials with the US Food and Drug Administration have approved a new generic of Diovan (valsartan), to help relieve the recent shortage of this critical medicine as a result of multiple recalls of generic valsartan products from several manufacturers. The recalls were prompted by a finding that certain lots of valsartan and other angiotensin II receptor blocker (ARB) medicines contain nitrosamine impurities.

For this approval, which was granted to Alkem Laboratories Limited, FDA officials gave a priority evaluation to the company’s manufacturing processes and also made sure they used appropriate testing methods to demonstrate that this valsartan product does not contain nitrosamine impurities.

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.